QTX-200 series (Quimatryx)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameQTX-200 series (Quimatryx)
Drug Alias NameDMNT inhibitors (Quimatryx)DNA methyltransferase 1 inhibitors (Ikerchem)DMNT 1 inhibitors (Ikerchem)IKDN
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA (cytosine-5)-methyltransferase 1 inhibitors
TargetsDNA (cytosine-5)-methyltransferase 1
Therapy Area/IndicationsNervous System DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySpain
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesQuimatryx
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesQuimatryx
Active IndicationsN/A
Inactive IndicationsNervous System DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A